Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Theralink Technologies Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
THER
Over the counter
8731
https://oncbiomune.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Theralink Technologies Inc
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
- Dec 18th, 2023 2:15 pm
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
- Nov 13th, 2023 7:15 pm
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
- Nov 3rd, 2023 1:15 pm
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
- Oct 4th, 2023 1:15 pm
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
- Jun 27th, 2023 1:20 pm
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
- May 23rd, 2023 12:30 pm
Scroll